• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病(COPD)治疗对支气管上皮细胞中多药耐药相关蛋白1(MRP1)介导转运的影响。

Effect of COPD treatments on MRP1-mediated transport in bronchial epithelial cells.

作者信息

van der Deen Margaretha, Homan Sandra, Timmer-Bosscha Hetty, Scheper Rik J, Timens Wim, Postma Dirkje S, de Vries Elisabeth G

机构信息

Department of Medical Oncology, University Medical Center Groningen, The Netherlands.

出版信息

Int J Chron Obstruct Pulmon Dis. 2008;3(3):469-75. doi: 10.2147/copd.s2817.

DOI:10.2147/copd.s2817
PMID:18990976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2629975/
Abstract

BACKGROUND

Smoking is the principle risk factor for development of chronic obstructive pulmonary disease (COPD). Multidrug resistance-associated protein 1 (MRP1) is known to protect against toxic compounds and oxidative stress, and might play a role in protection against smoke-induced disease progression. We questioned whether MRP1-mediated transport is influenced by pulmonary drugs that are commonly prescribed in COPD.

METHODS

The immortalized human bronchial epithelial cell line 16HBE14o- was used to analyze direct in vitro effects of budesonide, formoterol, ipratropium bromide and N-acetylcysteine (NAC) on MRP1-mediated transport. Carboxyfluorescein (CF) was used as a model MRP1 substrate and was measured with functional flow cytometry.

RESULTS

Formoterol had a minor effect, whereas budesonide concentration-dependently decreased CF transport by MRP1. Remarkably, addition of formoterol to the highest concentration of budesonide increased CF transport. Ipratropium bromide inhibited CF transport at low concentrations and tended to increase CF transport at higher levels. NAC increased CF transport by MRP1 in a concentration-dependent manner.

CONCLUSIONS

Our data suggest that, besides their positive effects on respiratory symptoms, budesonide, formoterol, ipratropium bromide, and NAC modulate MRP1 activity in bronchial epithelial cells. Further studies are required to assess whether stimulation of MRP1 activity is beneficial for long-term treatment of COPD.

摘要

背景

吸烟是慢性阻塞性肺疾病(COPD)发生的主要危险因素。已知多药耐药相关蛋白1(MRP1)可抵御有毒化合物和氧化应激,可能在预防烟雾诱导的疾病进展中发挥作用。我们质疑MRP1介导的转运是否受COPD常用肺部药物的影响。

方法

使用永生化人支气管上皮细胞系16HBE14o-分析布地奈德、福莫特罗、异丙托溴铵和N-乙酰半胱氨酸(NAC)对MRP1介导转运的直接体外作用。以羧基荧光素(CF)作为MRP1底物模型,采用功能性流式细胞术进行检测。

结果

福莫特罗作用较小,而布地奈德浓度依赖性地降低MRP1介导的CF转运。值得注意的是,在布地奈德最高浓度时加入福莫特罗可增加CF转运。异丙托溴铵在低浓度时抑制CF转运,在较高浓度时倾向于增加CF转运。NAC以浓度依赖性方式增加MRP1介导的CF转运。

结论

我们的数据表明,除了对呼吸道症状有积极作用外,布地奈德、福莫特罗、异丙托溴铵和NAC可调节支气管上皮细胞中的MRP1活性。需要进一步研究来评估刺激MRP1活性对COPD长期治疗是否有益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ff/2629975/5dd0521fdc27/copd-3-469f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ff/2629975/c09998d20515/copd-3-469f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ff/2629975/7cb144a9969b/copd-3-469f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ff/2629975/5dd0521fdc27/copd-3-469f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ff/2629975/c09998d20515/copd-3-469f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ff/2629975/7cb144a9969b/copd-3-469f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ff/2629975/5dd0521fdc27/copd-3-469f3.jpg

相似文献

1
Effect of COPD treatments on MRP1-mediated transport in bronchial epithelial cells.慢性阻塞性肺疾病(COPD)治疗对支气管上皮细胞中多药耐药相关蛋白1(MRP1)介导转运的影响。
Int J Chron Obstruct Pulmon Dis. 2008;3(3):469-75. doi: 10.2147/copd.s2817.
2
Cigarette smoke extract affects functional activity of MRP1 in bronchial epithelial cells.香烟烟雾提取物影响支气管上皮细胞中多药耐药相关蛋白1(MRP1)的功能活性。
J Biochem Mol Toxicol. 2007;21(5):243-51. doi: 10.1002/jbt.20187.
3
Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study.福莫特罗和异丙托溴铵对慢性阻塞性肺疾病的影响:一项为期3个月的安慰剂对照研究。
Eur Respir J. 2002 Nov;20(5):1138-46. doi: 10.1183/09031936.02.00301702.
4
Formoterol: a review of its use in chronic obstructive pulmonary disease.福莫特罗:其在慢性阻塞性肺疾病中应用的综述
Am J Respir Med. 2002;1(4):285-300. doi: 10.1007/BF03256622.
5
Treatment persistence and compliance with medications for chronic obstructive pulmonary disease.慢性阻塞性肺疾病的治疗持续性及药物依从性
Can Respir J. 2007 Jan-Feb;14(1):25-9. doi: 10.1155/2007/161652.
6
Multidetector-row computed tomography assessment of adding budesonide/formoterol to tiotropium in patients with chronic obstructive pulmonary disease.多排螺旋 CT 评估布地奈德/福莫特罗在慢性阻塞性肺疾病患者中联合噻托溴铵的疗效。
Pulm Pharmacol Ther. 2013 Jun;26(3):336-41. doi: 10.1016/j.pupt.2013.01.005. Epub 2013 Jan 20.
7
An economic assessment of inhaled formoterol dry powder versus ipratropium bromide pressurized metered dose inhaler in the treatment of chronic obstructive pulmonary disease.吸入用福莫特罗干粉剂与异丙托溴铵定量气雾剂治疗慢性阻塞性肺疾病的经济学评估
Clin Ther. 2003 Jan;25(1):285-97. doi: 10.1016/s0149-2918(03)90039-7.
8
Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus.布地奈德和福莫特罗可抑制被鼻病毒感染的支气管上皮细胞产生炎性介质。
Clin Exp Allergy. 2009 Nov;39(11):1700-10. doi: 10.1111/j.1365-2222.2009.03307.x. Epub 2009 Jun 22.
9
[Influence of huatanjiangqi prescription on multidrug resistance-associated protein 1 in human bronchial epithelial cells].
Zhong Yao Cai. 2014 Feb;37(2):280-3.
10
Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.噻托溴铵。关于其在慢性阻塞性肺疾病患者中作为维持治疗药物应用的综述。
Treat Respir Med. 2004;3(4):247-68. doi: 10.2165/00151829-200403040-00005.

引用本文的文献

1
Advances in the Use of -Acetylcysteine in Chronic Respiratory Diseases.N-乙酰半胱氨酸在慢性呼吸道疾病中的应用进展
Antioxidants (Basel). 2023 Sep 2;12(9):1713. doi: 10.3390/antiox12091713.
2
The Role of ABC Transporters in Lipid Metabolism and the Comorbid Course of Chronic Obstructive Pulmonary Disease and Atherosclerosis.ABC 转运蛋白在脂代谢及慢性阻塞性肺疾病和动脉粥样硬化合并症中的作用。
Int J Mol Sci. 2021 Jun 23;22(13):6711. doi: 10.3390/ijms22136711.
3
AITC induces MRP1 expression by protecting against CS/CSE-mediated DJ-1 protein degradation activation of the DJ-1/Nrf2 axis.

本文引用的文献

1
Diminished expression of multidrug resistance-associated protein 1 (MRP1) in bronchial epithelium of COPD patients.慢性阻塞性肺疾病(COPD)患者支气管上皮中多药耐药相关蛋白1(MRP1)表达降低。
Virchows Arch. 2006 Dec;449(6):682-8. doi: 10.1007/s00428-006-0240-3. Epub 2006 Oct 27.
2
Multidrug resistance-associated protein 1 (MRP1) mediated vincristine resistance: effects of N-acetylcysteine and Buthionine sulfoximine.多药耐药相关蛋白1(MRP1)介导的长春新碱耐药性:N-乙酰半胱氨酸和丁硫氨酸亚砜胺的作用
Cancer Cell Int. 2005 Jul 24;5(1):22. doi: 10.1186/1475-2867-5-22.
3
ATP-binding cassette (ABC) transporters in normal and pathological lung.
AITC通过防止CS/CSE介导的DJ-1蛋白降解激活DJ-1/Nrf2轴来诱导MRP1表达。
Korean J Physiol Pharmacol. 2020 Nov 1;24(6):481-492. doi: 10.4196/kjpp.2020.24.6.481.
4
Tobacco Smoke and Inhaled Drugs Alter Expression and Activity of Multidrug Resistance-Associated Protein-1 (MRP1) in Human Distal Lung Epithelial Cells .烟草烟雾和吸入性药物改变人远端肺上皮细胞中多药耐药相关蛋白1(MRP1)的表达和活性。
Front Bioeng Biotechnol. 2020 Sep 8;8:1030. doi: 10.3389/fbioe.2020.01030. eCollection 2020.
5
Selective ATP-Binding Cassette Subfamily C Gene Expression and Proinflammatory Mediators Released by BEAS-2B after PM, Budesonide, and Cotreated Exposures.经 PM、布地奈德和联合处理暴露后,BEAS-2B 细胞选择性三磷酸腺苷结合盒 C 基因表达和促炎介质的释放。
Mediators Inflamm. 2017;2017:6827194. doi: 10.1155/2017/6827194. Epub 2017 Aug 16.
6
Upregulation of Multidrug Resistance-Associated Protein 1 by Allyl Isothiocyanate in Human Bronchial Epithelial Cell: Involvement of c-Jun N-Terminal Kinase Signaling Pathway.异硫氰酸烯丙酯对人支气管上皮细胞多药耐药相关蛋白1的上调作用:c-Jun氨基末端激酶信号通路的参与
Oxid Med Cell Longev. 2015;2015:903782. doi: 10.1155/2015/903782. Epub 2015 Jul 27.
7
Gene expression analysis of membrane transporters and drug-metabolizing enzymes in the lung of healthy and COPD subjects.健康人群和 COPD 患者肺部膜转运体和药物代谢酶的基因表达分析。
Pharmacol Res Perspect. 2014 Aug;2(4):e00054. doi: 10.1002/prp2.54. Epub 2014 Jun 12.
8
Allyl isothiocyanate increases MRP1 function and expression in a human bronchial epithelial cell line.异硫氰酸烯丙酯可增强人支气管上皮细胞系中多药耐药相关蛋白1(MRP1)的功能及表达。
Oxid Med Cell Longev. 2014;2014:547379. doi: 10.1155/2014/547379. Epub 2014 Jan 14.
9
Inhaled chemotherapy in lung cancer: future concept of nanomedicine.肺癌的吸入化疗:纳米医学的未来概念。
Int J Nanomedicine. 2012;7:1551-72. doi: 10.2147/IJN.S29997. Epub 2012 Mar 22.
正常及病理状态下肺组织中的ATP结合盒(ABC)转运蛋白
Respir Res. 2005 Jun 20;6(1):59. doi: 10.1186/1465-9921-6-59.
4
Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial.N-乙酰半胱氨酸对慢性阻塞性肺疾病预后的影响(N-乙酰半胱氨酸成本-效用研究中的支气管炎随机试验,BRONCUS):一项随机安慰剂对照试验
Lancet. 2005;365(9470):1552-60. doi: 10.1016/S0140-6736(05)66456-2.
5
Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease.布地奈德与福莫特罗用于慢性阻塞性肺疾病的维持治疗
Eur Respir J. 2003 Dec;22(6):912-9. doi: 10.1183/09031936.03.00027003.
6
Review of the unique properties of budesonide.布地奈德独特性质的综述。
Clin Ther. 2003;25 Suppl C:C42-60. doi: 10.1016/s0149-2918(03)80305-3.
7
Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis.吸入性糖皮质激素可减缓慢性阻塞性肺疾病气流受限的进展:一项荟萃分析。
Thorax. 2003 Nov;58(11):937-41. doi: 10.1136/thorax.58.11.937.
8
Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells.完整细胞中MRP4和MRP5介导的环核苷酸转运的特性分析。
J Biol Chem. 2003 May 16;278(20):17664-71. doi: 10.1074/jbc.M212723200. Epub 2003 Mar 13.
9
Real-time reverse transcription-PCR expression profiling of the complete human ATP-binding cassette transporter superfamily in various tissues.人类ATP结合盒转运蛋白超家族在各种组织中的实时逆转录PCR表达谱分析。
Clin Chem. 2003 Feb;49(2):230-8. doi: 10.1373/49.2.230.
10
Transport and local metabolism of budesonide and fluticasone propionate in a human bronchial epithelial cell line (Calu-3).布地奈德和丙酸氟替卡松在人支气管上皮细胞系(Calu-3)中的转运与局部代谢
J Pharm Sci. 2002 Jun;91(6):1561-7. doi: 10.1002/jps.10151.